 | • レポートコード：QYR9ST00300 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、アルファサラセミア治療の世界市場について調査・分析し、アルファサラセミア治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（葉酸、デフェラシロクス、デフェリプロン、ヒドロキシ尿素）、用途別（病院、外来手術センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のアルファサラセミア治療市場動向 ・主要企業別マーケットシェア ・アルファサラセミア治療の種類別市場規模2014-2019 （葉酸、デフェラシロクス、デフェリプロン、ヒドロキシ尿素） ・アルファサラセミア治療の用途別市場規模2014-2019 （病院、外来手術センター、その他） ・アルファサラセミア治療の北米市場：主要企業・種類別/用途別市場規模 ・アルファサラセミア治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・アルファサラセミア治療の中国市場：主要企業・種類別/用途別市場規模 ・アルファサラセミア治療の日本国内市場：主要企業・種類別/用途別市場規模 ・アルファサラセミア治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・アルファサラセミア治療のインド市場：主要企業・種類別/用途別市場規模 ・アルファサラセミア治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GlaxoSmithKline、Novartis AG、Bellicum Pharmaceuticals、Acceleron Pharma、Johnson & Johnson、Merck & Co.、Gilead Sciences, Inc.） ・アルファサラセミア治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Alpha thalassemia causes due to deficiency or absence of alpha globin chains results in alpha thalassemia which is asymptomatic with general hematologic findings and gains silent carrier status. In 2018, the global Alpha Thalassemia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Alpha Thalassemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alpha Thalassemia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
GlaxoSmithKline
Novartis AG
Bellicum Pharmaceuticals
Acceleron Pharma
Johnson & Johnson
Merck & Co.
Gilead Sciences, Inc.
…
Market segment by Type, the product can be split into
Folic Acid
Deferasirox
Deferiprone
Hydroxyurea
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Alpha Thalassemia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Alpha Thalassemia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Alpha Thalassemia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Alpha Thalassemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Folic Acid
1.4.3 Deferasirox
1.4.4 Deferiprone
1.4.5 Hydroxyurea
1.5 Market by Application
1.5.1 Global Alpha Thalassemia Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Alpha Thalassemia Treatment Market Size
2.2 Alpha Thalassemia Treatment Growth Trends by Regions
2.2.1 Alpha Thalassemia Treatment Market Size by Regions (2019-2025)
2.2.2 Alpha Thalassemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Alpha Thalassemia Treatment Market Size by by Players
3.1.1 Global Alpha Thalassemia Treatment Revenue by by Players (2014-2019)
3.1.2 Global Alpha Thalassemia Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Alpha Thalassemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Alpha Thalassemia Treatment Key Players Head office and Area Served
3.3 Key Players Alpha Thalassemia Treatment Product/Solution/Service
3.4 Date of Enter into Alpha Thalassemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Alpha Thalassemia Treatment Market Size by Type (2014-2019)
4.2 Global Alpha Thalassemia Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Alpha Thalassemia Treatment Market Size (2014-2019)
5.2 Alpha Thalassemia Treatment Key Players in North America
5.3 North America Alpha Thalassemia Treatment Market Size by Type
5.4 North America Alpha Thalassemia Treatment Market Size by Application
6 Europe
6.1 Europe Alpha Thalassemia Treatment Market Size (2014-2019)
6.2 Alpha Thalassemia Treatment Key Players in Europe
6.3 Europe Alpha Thalassemia Treatment Market Size by Type
6.4 Europe Alpha Thalassemia Treatment Market Size by Application
7 China
7.1 China Alpha Thalassemia Treatment Market Size (2014-2019)
7.2 Alpha Thalassemia Treatment Key Players in China
7.3 China Alpha Thalassemia Treatment Market Size by Type
7.4 China Alpha Thalassemia Treatment Market Size by Application
8 Japan
8.1 Japan Alpha Thalassemia Treatment Market Size (2014-2019)
8.2 Alpha Thalassemia Treatment Key Players in Japan
8.3 Japan Alpha Thalassemia Treatment Market Size by Type
8.4 Japan Alpha Thalassemia Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Alpha Thalassemia Treatment Market Size (2014-2019)
9.2 Alpha Thalassemia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Alpha Thalassemia Treatment Market Size by Type
9.4 Southeast Asia Alpha Thalassemia Treatment Market Size by Application
10 India
10.1 India Alpha Thalassemia Treatment Market Size (2014-2019)
10.2 Alpha Thalassemia Treatment Key Players in India
10.3 India Alpha Thalassemia Treatment Market Size by Type
10.4 India Alpha Thalassemia Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Alpha Thalassemia Treatment Market Size (2014-2019)
11.2 Alpha Thalassemia Treatment Key Players in Central & South America
11.3 Central & South America Alpha Thalassemia Treatment Market Size by Type
11.4 Central & South America Alpha Thalassemia Treatment Market Size by Application
12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Alpha Thalassemia Treatment Introduction
12.1.4 GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2014-2019))
12.1.5 GlaxoSmithKline Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Company Details
12.2.2 Company Description and Business Overview
12.2.3 Alpha Thalassemia Treatment Introduction
12.2.4 Novartis AG Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.2.5 Novartis AG Recent Development
12.3 Bellicum Pharmaceuticals
12.3.1 Bellicum Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Alpha Thalassemia Treatment Introduction
12.3.4 Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.3.5 Bellicum Pharmaceuticals Recent Development
12.4 Acceleron Pharma
12.4.1 Acceleron Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Alpha Thalassemia Treatment Introduction
12.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.4.5 Acceleron Pharma Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Alpha Thalassemia Treatment Introduction
12.5.4 Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Merck & Co.
12.6.1 Merck & Co. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Alpha Thalassemia Treatment Introduction
12.6.4 Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.6.5 Merck & Co. Recent Development
12.7 Gilead Sciences, Inc.
12.7.1 Gilead Sciences, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Alpha Thalassemia Treatment Introduction
12.7.4 Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.7.5 Gilead Sciences, Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Alpha Thalassemia Treatment Key Market Segments
Table Key Players Alpha Thalassemia Treatment Covered
Table Global Alpha Thalassemia Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Folic Acid Figures
Table Key Players of Folic Acid
Figuer Deferasirox Figures
Table Key Players of Deferasirox
Figuer Deferiprone Figures
Table Key Players of Deferiprone
Figuer Hydroxyurea Figures
Table Key Players of Hydroxyurea
Table Global Alpha Thalassemia Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Alpha Thalassemia Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Alpha Thalassemia Treatment Report Years Considered
Figure Global Alpha Thalassemia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Alpha Thalassemia Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Alpha Thalassemia Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Alpha Thalassemia Treatment Market Share by Regions 2014-2019
Figure Global Alpha Thalassemia Treatment Market Share by Regions 2014-2019
Figure Global Alpha Thalassemia Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Alpha Thalassemia Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Alpha Thalassemia Treatment Market Share by by Players (2014-2019)
Figure Global Alpha Thalassemia Treatment Market Share by by Players in 2018
Table Global Alpha Thalassemia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Alpha Thalassemia Treatment Product/Solution/Service
Table Date of Enter into Alpha Thalassemia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Alpha Thalassemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Alpha Thalassemia Treatment Market Size Share by Type (2014-2019)
Figure Global Alpha Thalassemia Treatment Market Size Market Share by Type (2014-2019)
Table Global Alpha Thalassemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Alpha Thalassemia Treatment Market Size Share by Application (2014-2019)
Figure Global Alpha Thalassemia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Alpha Thalassemia Treatment Revenue Market Share by Application in 2018
Figure North America Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Alpha Thalassemia Treatment Market Share (2018-2019)
Table North America Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Alpha Thalassemia Treatment Market Share by Type 2014-2019
Table North America Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Alpha Thalassemia Treatment Market Share by Application 2014-2019
Figure Europe Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Alpha Thalassemia Treatment Market Share (2018-2019)
Table Europe Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Alpha Thalassemia Treatment Market Share by Type 2014-2019
Table Europe Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Alpha Thalassemia Treatment Market Share by Application 2014-2019
Figure China Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Alpha Thalassemia Treatment Market Share (2018-2019)
Table China Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$)
Table China Alpha Thalassemia Treatment Market Share by Type 2014-2019
Table China Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$)
Table China Alpha Thalassemia Treatment Market Share by Application 2014-2019
Figure Japan Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Alpha Thalassemia Treatment Market Share (2018-2019)
Table Japan Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Alpha Thalassemia Treatment Market Share by Type 2014-2019
Table Japan Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Alpha Thalassemia Treatment Market Share by Application 2014-2019
Figure Southeast Asia Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Alpha Thalassemia Treatment Market Share (2018-2019)
Table Southeast Asia Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Alpha Thalassemia Treatment Market Share by Type 2014-2019
Table Southeast Asia Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Alpha Thalassemia Treatment Market Share by Application 2014-2019
Figure India Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Alpha Thalassemia Treatment Market Share (2018-2019)
Table India Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$)
Table India Alpha Thalassemia Treatment Market Share by Type 2014-2019
Table India Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$)
Table India Alpha Thalassemia Treatment Market Share by Application 2014-2019
Figure Central & South America Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Alpha Thalassemia Treatment Market Share (2018-2019)
Table Central & South America Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Alpha Thalassemia Treatment Market Share by Type 2014-2019
Table Central & South America Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Alpha Thalassemia Treatment Market Share by Application 2014-2019
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019)
Table Novartis AG Recent Development
Table Bellicum Pharmaceuticals Company Details
Table Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$)
Figure Bellicum Pharmaceuticals Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019)
Table Bellicum Pharmaceuticals Recent Development
Table Acceleron Pharma Company Details
Table Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$)
Figure Acceleron Pharma Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019)
Table Acceleron Pharma Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$)
Figure Merck & Co. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019)
Table Merck & Co. Recent Development
Table Gilead Sciences, Inc. Company Details
Table Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$)
Figure Gilead Sciences, Inc. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019)
Table Gilead Sciences, Inc. Recent Development
Table Global Alpha Thalassemia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Alpha Thalassemia Treatment Market Size Share by Regions (2019-2025)
Figure Global Alpha Thalassemia Treatment Market Size Share by Regions in 2025
Figure North America Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Alpha Thalassemia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Alpha Thalassemia Treatment Market Size by Product (2019-2025)
Figure Global Alpha Thalassemia Treatment Market Size by Product in 2025
Table Global Alpha Thalassemia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Alpha Thalassemia Treatment Market Size by Application (2019-2025)
Figure Global Alpha Thalassemia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
超音波による本態性振戦治療の世界市場：市場規模・現状・予測 Essential tremors are involuntary trembling in one or more parts of body. Essential tremors treatment with ultrasound market is supposed to be driven by factors such as increase in age related neurological disorder. FDA approvals for clinical trials and huge inflow of new players entering the market…- 世界の葉酸注射液市場：専門的調査 Folic Acid Injection is a sterile, nonpyrogenic solution of sodium folate prepared by the addition of sodium hydroxide to folic acid in Water for Injection intended for intramuscular, intravenous or subcutaneous use. Folic acid is a B-complex vitamin needed to form healthy cells, especially red bloo…
- 腹水治療の世界市場：市場規模・現状・予測 Ascites is an abnormal accumulation of fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension.North America and Europe together account for largest market share in the overall ascites treatment market. Highly devel…
- 網膜色素変性症治療＆管理の世界市場：市場規模・現状・予測 Retinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision.Retinitis pigmentosa is generally inherited from a person's parents. Mutations in one of more than 50 genes is involved. In 2018, the global Retinitis Pigmentosa Treatment & Management market size was xx million U…
- 副腎皮質癌治療の世界市場：市場規模・現状・予測 Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…